{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:47:30Z","timestamp":1752230850039,"version":"3.41.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015034","name":"Shahid Sadoughi University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.urolonc.2024.12.273","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:14:45Z","timestamp":1736597685000},"page":"393.e9-393.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Study of urine-based mRNA biomarkers for early detection of nonmuscle invasive bladder cancer (NMIBC)"],"prefix":"10.1016","volume":"43","author":[{"given":"Omid","family":"Abazari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryamsadat","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Dayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serajoddin","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood Akhavan","family":"Tafti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Zavarreza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.12.273_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0003","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1002\/ctd2.176","article-title":"Urine-based liquid biopsy in bladder cancer: oopportunities and challenges","volume":"3","author":"Wang","year":"2023","journal-title":"Clin Transl Discov"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0004","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s00345-023-04689-1","article-title":"Positioning the role of urine cytology within the diagnostic pathway for UTUC: supportive but inconclusive","volume":"41","author":"Figaroa","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103577","article-title":"Liquid biopsy in bladder cancer: state of the art and future perspectives","volume":"170","author":"Crocetto","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0006","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/cancers16040803","article-title":"New perspectives on the role of liquid biopsy in bladder cancer: aapplicability to precision medicine","volume":"16","author":"Alberca-del Arco","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0008","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0009","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.18632\/oncotarget.24436","article-title":"Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0010","doi-asserted-by":"crossref","first-page":"58193","DOI":"10.18632\/oncotarget.11277","article-title":"UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euo.2020.09.001","article-title":"Validation of an mRNA-based urine test for the detection of bladder cancer in patients with haematuria","volume":"4","author":"van Valenberg","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/RRU.S232417","article-title":"Bladder cancer in Iran: an epidemiological review","volume":"12","author":"Kalan Farmanfarma","year":"2020","journal-title":"Res Reports Urol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0013","first-page":"283","article-title":"Estimating the prevalence of bladder cancer by stage in Iran as a developing country","volume":"36","author":"Rashidian","year":"2022","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4149\/neo_2021_210219N226","article-title":"The role of corticotropin-releasing hormone (CRH) family in tumors","volume":"68","author":"Su-Qin","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0015","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.2147\/CMAR.S198348","article-title":"Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma","volume":"11","author":"Farid","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0016","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s10528-022-10223-6","article-title":"CDC42 regulates cell proliferation and apoptosis in bladder cancer via the IQGAP3-mediated ras\/ERK pathway","volume":"60","author":"Li","year":"2022","journal-title":"Biochem Genet"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0017","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/pharmaceutics13111959","article-title":"Role of surviving in bladder cancer: issues to be overcome when designing an efficient dual nano-therapy","volume":"13","author":"Arista-Romero","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.humpath.2022.06.005","article-title":"Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management","volume":"133","author":"Cheng","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12894-022-01074-9","article-title":"Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma","volume":"22","author":"Xiang","year":"2022","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5814-y","article-title":"Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms","volume":"19","author":"Zeng","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0021","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/07357907.2018.1514504","article-title":"Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals","volume":"36","author":"Seyedabadi","year":"2018","journal-title":"Cancer Invest"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0022","first-page":"497","article-title":"Bladder cancer risk stratification using a urinary mRNA biomarker panel\u2013a path towards cystoscopy triaging","volume":"39","author":"Shkolyar","year":"2021","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0023","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer\u2014Current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bdq.2019.100090","article-title":"For what factors should we normalize urinary extracellular mRNA biomarkers?","volume":"17","author":"Gunasekaran","year":"2019","journal-title":"Biomol Detect Quantif"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2017.12.009","article-title":"mRNA, microRNA and lncRNA as novel bladder tumor markers","volume":"477","author":"Wieczorek","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0026","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1158\/1078-0432.CCR-09-3373","article-title":"Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma","volume":"16","author":"Mengual","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmoldx.2020.10.005","article-title":"UriBLAD: a urine-based gene expression assay for noninvasive detection of bladder cancer","volume":"23","author":"Wang","year":"2021","journal-title":"J Mol Diagnostics"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0029","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/ijms19010226","article-title":"Evaluation of a new surviving ELISA and UBC\u00ae rapid for the detection of bladder cancer in urine","volume":"19","author":"Gleichenhagen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2024.12.273_bib0031","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.3390\/ijms241814374","article-title":"Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers","volume":"24","author":"Flores Monar","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924010500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924010500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:38:22Z","timestamp":1747816702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924010500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1078143924010500"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.273","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of urine-based mRNA biomarkers for early detection of nonmuscle invasive bladder cancer (NMIBC)","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}